Yüklüyor......
The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
Rituximab is considered to be a promising drug for treating childhood refractory nephrotic syndrome. However, the efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome remain inconclusive. This meta-analysis aimed to investigate the efficacy and safety of rituximab tre...
Kaydedildi:
| Yayımlandı: | Sci Rep |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4314653/ https://ncbi.nlm.nih.gov/pubmed/25645999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep08219 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|